Especially since a negative amyloid marker firmly rules out AD, although co-pathology of AD may occur in sv-PPA and av-PPA, yielding positive amyloid biomarkers, while the causative underlying pathology may be non-AD (e.g., TDP43 or tau pathology). The gene discussed is MAPT; the disease is Alzheimer disease.